ImmusanT Competitors and Similar CompaniesClear all
ImmusanT's competitors and similar companies include Mesoblast and Harmony Biosciences.
 ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. |  Harmony Biosciences Harmony Biosciences develops therapies to help patients with unmet medical needs. | |
Founding Date | Founding Date 2010 | Founding Date 2004 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Plymouth Meeting, US HQ |
Employees | Employees 2 | Employees 73 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 2.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) $868.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $1.2m (FY, 2025) | Cost of goods $198.3m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $16.1m (FY, 2025) | Gross profit $670.1m (FY, 2025) |
Net income | Net income N/A | Net income ($102.1m) (FY, 2025) | Net income $158.7m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 72.8m | Total funding raised $ 56.2m | Total funding raised $ 270m |
For sources of this data, please see the company profile
View Company Profiles
Mesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View companyHarmony Biosciences
HQ
Plymouth Meeting, US
Harmony Biosciences develops therapies to help patients with unmet medical needs.
View company